Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q4 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $282 thousand versus the consensus estimate of $279 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.